Oxytetracycline have the therapeutic efficiency in CD133+ HCC population through suppression CD133 expression by decreasing of protein stability of CD133
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oxytetracycline have the therapeutic efficiency in CD133+ HCC population through suppression CD133 expression by decreasing of protein stability of CD133
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-25
DOI
10.1038/s41598-018-34301-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential mechanisms of CD133 in cancer stem cells
- (2017) Jae-Woo Jang et al. LIFE SCIENCES
- Hepatocellular carcinoma-targeted drug discovery through image-based phenotypic screening in co-cultures of HCC cells with hepatocytes
- (2016) Jae-Woo Jang et al. BMC CANCER
- Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
- (2015) Rebecca Lamb et al. Oncotarget
- Effect of mitochondrial metabolism-interfering agents on cancer cell mitochondrial function and radio/chemosensitivity
- (2014) Achilleas G. Mitrakas et al. ANTI-CANCER DRUGS
- Cancer Stem Cells: The ‘Achilles Heel’ of Chemo-Resistant Tumors
- (2014) In-Sun Hong et al. Recent Patents on Anti-Cancer Drug Discovery
- Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
- (2013) H. A. Yu et al. CLINICAL CANCER RESEARCH
- Genetics and biomarkers in personalisation of lung cancer treatment
- (2013) Rafael Rosell et al. LANCET
- Cancer stem cells: The challenges ahead
- (2013) Jan Paul Medema NATURE CELL BIOLOGY
- Clinical Implications of Cancer Stem Cell Biology in Hepatocellular Carcinoma
- (2012) Junfang Ji et al. SEMINARS IN ONCOLOGY
- Regulation of CD133 by HDAC6 Promotes β-Catenin Signaling to Suppress Cancer Cell Differentiation
- (2012) Anthony B. Mak et al. Cell Reports
- Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma
- (2010) Keisuke Kohga et al. JOURNAL OF HEPATOLOGY
- Clinical and economic value of screening for Kras mutations as predictors of response to epidermal growth factor receptor inhibitors
- (2009) E. E. Mancl et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
- (2009) Rafael Rosell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
- (2009) A Soeda et al. ONCOGENE
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started